October 12, 2018 - Orgenesis, Inc. (NASDAQ:ORGS) has filed a financial statement reporting Common Stock Shares Outstanding of $13,620,262 USD. Previously, on July 17, 2018, Orgenesis, Inc. reported Common Stock Shares Outstanding of $13,300,676 USD. This represents a change of 2.40% in Common Stock Shares Outstanding.

Period EndPeriodValue
2018-08-31 2018-Q3 13,620,262
2018-05-31 2018-Q2 13,300,676
2018-02-28 2018-Q1 10,273,301
2017-11-30 2017-Q4 9,872,659
2016-11-30 2016-Q4 9,508,068
2015-11-30 2015-Q4 55,835,950
2015-02-28 2015-Q1 55,970,565
2014-11-30 2014-Q4 55,970,565
2014-08-31 2014-Q3 55,172,617
2014-05-31 2014-Q2 54,244,914
2014-02-28 2014-Q1 53,147,276
2013-11-30 2013-Q4 51,144,621
2013-08-31 2013-Q3 51,144,621
2013-05-31 2013-Q2 51,144,621
2013-02-28 2013-Q1 49,617,903
2012-11-30 2012-Q4 49,117,903
2012-08-31 2012-Q3 49,117,903
2012-05-31 2012-Q2 48,617,903
2012-02-29 2012-Q1 48,517,903
2011-11-30 2011-Q4 80,500,000
2010-11-30 2010-Q4 80,500,000

Other Interesting Charts

Cost Of Revenue - Deferred Revenue Current - General And Administrative Expense - Income Tax Expense Benefit - Increase Decrease In Deferred Revenue - Increase Decrease In Prepaid Expense - Interest Expense Short Term Borrowings - Other Nonoperating Income Expense - Prepaid Expense Current - Research And Development Expense - Revenues - Schedule Of Financial Expenses Zero Three Eight Four Zero Zero Mbr Four Ryn Tk MKW - Schedule Of Financial Expenses Zero Three Eight Four Zero Zero N Ky Fourtr Sb N Eightc T - Schedule Of Financial Expenses Zero Three Eight Four Zero Zero Onen Fivedv Bmb CP Zerob - Schedule Of Financial Expenses Zero Three Eight Four Zero Zero QJ Eight QH Eightv Kr PTQ - Schedule Of Financial Expenses Zero Three Eight Four Zero Zero Six V Scn Ty Three Eight TNX - Schedule Of Financial Expenses Zero Three Eight Four Zero Zero Srrhx Five Eightxb Ql Seven - Schedule Of Financial Expenses Zero Three Eight Four Zero Zero TH Seven Fk NT Wy Four CJ - Schedule Of Financial Expenses Zero Three Eight Four Zero Zero Two Fivef Sixggwb HL Hk - Schedule Of Financial Expenses Zero Three Eight Four Zero Zero Vpvvm Two Five H Mcck - Schedule Of Financial Expenses Zero Three Eight Four Zero Zero Zp Qmcvvc Rzm Four - Schedule Of Financial Expenses Zero Three Eight Four Zero Zerohd Rb G Vt Six G One Wh - Schedule Of Financial Expenses Zero Three Eight Four Zero Zeroz H Foury Nx K Three F Four Gb - Schedule Of Intangible Assets Future Amortization Expense Zero Three Eight Four Zero Zero Four Gq H Kp PH Onevr G - Schedule Of Intangible Assets Future Amortization Expense Zero Three Eight Four Zero Zerob Ts Km Sevenv VK Sc B - Schedule Of Research And Development Expenses Zero Three Eight Four Zero Zero Four L Mf Q Fc MBTX Zero - Schedule Of Research And Development Expenses Zero Three Eight Four Zero Zerodd PF Twol Pm T Six HN - Schedule Of Research And Development Expenses Zero Three Eight Four Zero Zerofpd Tg J Eightdr KRS - Schedule Of Research And Development Expenses Zero Three Eight Four Zero Zerol Dp QD One T Zero FM Two Nine - Schedule Of Research And Development Expenses Zero Three Eight Four Zero Zeroshm K Pl BD Jbt Four - Schedule Of Research And Development Expenses Zero Three Eight Four Zero Zerov G Lm Qlm N Six Zerok T - Schedule Of Research And Development Expenses Zero Three Eight Four Zero Zerox Zt Eighttq Xt Pl FV - Schedule Of Revenue Zero Three Eight Four Zero Zero Eight Nine Xw R Eightzv Five Three Td - Schedule Of Revenue Zero Three Eight Four Zero Zero Eightwp C Four Twom F Fourhg Eight - Schedule Of Revenue Zero Three Eight Four Zero Zero Kcw Vnh Zero Nz Mt Four - Schedule Of Revenue Zero Three Eight Four Zero Zerottt P Five Z Rh C One Jr - Schedule Of Revenue Zero Three Eight Four Zero Zeroyfm Eightc BS Mkcg Five - Schedule Of Revenue Zero Three Eight Four Zero Zeroz M Three Six Fkqmg Ss R - Schedule Of Revenues From Major Customers Zero Three Eight Four Zero Zero T Jt WLZNZ Cl Fk - Schedule Of Revenues From Major Customers Zero Three Eight Four Zero Zero T Seven M Kgx C Three W Four D Four - Schedule Of Revenues From Major Customers Zero Three Eight Four Zero Zero Two N Ninex Fiveg WDT Rsl - Schedule Of Revenues From Major Customers Zero Three Eight Four Zero Zero Xls BM Sevenv Eight Onenr M - Schedule Of Revenues From Major Customers Zero Three Eight Four Zero Zerof K Fivex One Fiveyb Tfps - Schedule Of Revenues From Major Customers Zero Three Eight Four Zero Zerox Two Nq Fourrg Kb J Four Three - Stock Based Compensation Expenses Related To Options Granted To Employees And Directors -

Related News Stories

Orgenesis, Inc. - Overlooked Stock In The Gene Therapy Contract Development With R&D Pipeline

2018-06-03 seekingalpha
Overlooked specialty contract development and manufacturing stock in the exciting field of advanced cell therapy with a potential for an exponential upside. (184-3)

CUSIP: 68619K105